IBEX Ltd
IBEXNasdaqTechnology · Services-Computer Processing & Data Preparation · D0 · SEC filings ↗ · Compare ⊕
View price & chart on Yahoo Finance ↗Financials
SEC XBRL · annual| FY25 | FY24 | FY23 | FY22 | FY21 | |
|---|---|---|---|---|---|
| Revenue | $558.3M | $508.6M | $523.1M | $492.9M | $443.4M |
| Operating income | $46.6M | $39.4M | $40.5M | $20.6M | $17.0M |
| Net income | $36.9M | $33.7M | $31.6M | $21.5M | $13.1M |
| Total assets | $273.2M | $293.9M | $293.3M | $294.2M | — |
| Total liabilities | $138.9M | $128.1M | $143.4M | $180.7M | — |
| Equity | $134.3M | $165.8M | $150.0M | $113.5M | $94.7M |
| EPS (diluted) | $2.36 | $1.84 | $1.67 | $1.15 | $0.71 |
| Shares out. | 13.3M | 16.8M | 18.3M | 18.2M | 18.4M |
Reported figures from the company's SEC filings (XBRL). Blank where a line item isn't cleanly tagged — never estimated.
Key ratios
from filings · FY2025- Operating margin
- 8.3%
- Net margin
- 6.6%
- Return on equity
- 27.4%
- Return on assets
- 13.5%
- Return on capital (ROCE)
- 24.1%
- Liabilities / assets
- 50.8%
- Debt / equity
- 1.03×
- Book value / share
- $10.09
- Revenue growth (YoY)
- 9.8%
- Net income growth (YoY)
- 9.5%
Computed from the company's own SEC figures — no market price, so these are facts, not a valuation. Book value per share is reported equity ÷ shares; it is not the stock price.
Financial health
forensic scores · FY2025- Altman Z″ (distress)
- 4.05safe
- Accruals / assets
- −3.2%clean
- Piotroski F-Score
- 7/9strong
Altman Z″is a textbook bankruptcy-distress score from book values only (>2.6 safe · 1.1–2.6 grey · <1.1 distress). Accruals = (net income − operating cash flow) ÷ assets; persistently high accruals are an earnings-quality red flag. Beneish M-Scoreis an eight-ratio screen comparing this year with last (M > −1.78 = elevated manipulation-risk screen, not proof). Piotroski F-Scorecounts how many of nine fundamental-health checks pass (shown as passed / applicable; we use operating margin and total liabilities as documented proxies where the exact input isn't XBRL-tagged). Computed from SEC filings — descriptive factors, not advice or a forecast.
Quality score
EDS ScoreOur own multi-factor score from free SEC data — profitability, growth, financial strength, earnings quality, and event/ownership catalysts. No market price and no licensed model: each axis is the share of source-backed checks it passes. Descriptive factors, not advice or a forecast. What these scores mean →
Signs
● 6 good- Operating margin is positive
- Strong return on equity (>15%)
- Revenue is growing year-over-year
- Positive operating cash flow
- Clean earnings (low accruals)
- Altman Z″ in the safe zone
Derived from the company's own SEC figures (fundamentals, forensic scores, filing discipline) — descriptive factors, not advice or a forecast.
5%+ owners
SEC Schedule 13D / 13G · last 3 yrs- American Century Investment Management IncPassive (13G)May 1, 2026
- Jpmorgan Chase & CoPassive (13G)May 5, 2025
- Pinebridge Gem Ii G.P., L.P.Activist (13D)Feb 27, 2025
Holders who disclosed a 5%+ stake. 13D signals intent to influence or control; 13G is a passive holding. Latest filing per holder — open it for the exact stake.
Insider transactions
SEC Form 4 · most recent| Insider | Date | Type | Shares | Price |
|---|---|---|---|---|
| Mcginnis PatrickDirector | May 28, 2026 | Sell | 1,030 | $31.69 |
| Greenwald Taylor COfficer — Chief Financial Officer | May 22, 2026 | Grant | 3,333 | $0.00 |
| Dechant Robert ThomasOfficer — Chief Executive Officer | May 13, 2026 | Sell | 7,800 | $30.50 |
| Dawson Bruce NeilOfficer — Chief Sales and CS Officer | May 11, 2026 | Sell | 3,129 | $32.80 |
| Ballou-Aares DaniellaDirector | Mar 13, 2025 | Sell | 5,843 | $24.22 |
| Jones John WilliamDirector | Mar 2, 2026 | Grant | 2,250 | $0.00 |
| Zhuang MingzheDirector | Mar 2, 2026 | Grant | 2,083 | $0.00 |
| Ballou-Aares DaniellaDirector | Mar 2, 2026 | Grant | 2,083 | $0.00 |
| Mcginnis PatrickDirector | Mar 2, 2026 | Grant | 2,083 | $0.00 |
| Beck Fiona ElizabethDirector | Mar 2, 2026 | Grant | 2,083 | $0.00 |
| Batungbacal KarenDirector | Mar 2, 2026 | Grant | 2,083 | $0.00 |
| Keen ShujaDirector | Mar 2, 2026 | Grant | 5,000 | $0.00 |
Headline trade per Form 4 (officers, directors, 10%+ owners). Buy/sell read from the filing's structured data — blank where a field isn't cleanly tagged.
Short interest
FINRA · bi-monthly| Settlement | Shares short | Days to cover | Δ vs prior |
|---|---|---|---|
| May 15, 2026 | 142,860 | 1.1 | -9.4% |
| Apr 30, 2026 | 157,662 | 1.4 | -4.6% |
| Apr 15, 2026 | 165,190 | 1.7 | -13.2% |
| Mar 31, 2026 | 190,296 | 1.4 | -10.7% |
| Mar 13, 2026 | 213,169 | 1.6 | +12.1% |
Shares sold short as reported to FINRA. Days-to-cover = short shares ÷ average daily volume — higher means more potential squeeze pressure.
Material events
SEC Form 8-K · most recent- Other material eventMay 13, 2026
- Results of operationsMay 6, 2026
- Results of operationsFeb 5, 2026
- Director / officer changeDec 19, 2025
- Director / officer change · Shareholder voteDec 10, 2025
- Director / officer changeNov 24, 2025
- Results of operationsNov 6, 2025
- Results of operationsSep 11, 2025
Events the company reported on Form 8-K, labelled by the SEC item code it filed under — its own classification, not our interpretation.
Recent SEC filings
All filings ↗Event-driven situations (2)
Spot an error in this record? Report it. Every correction is verified against the source filing before we change anything.